.png){kind=icon}
返回
Mitochondrial dysfunction in psychiatric disorders
.png){kind=icon}
PRE
AI
DOI：10.1016/j.schres.2022.08.027.png)
.png){kind=icon}
原文求助.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
Psychiatric disorders are a heterogeneous group of mental disorders with abnormal mental or behavioral patterns, which severely distress or disable affected individuals and can have a grave socioeconomic burden. Growing evidence indicates that mitochondrial function plays an important role in developing psychiatric disorders. This review discusses the neuropsychiatric consequences of mitochondrial abnormalities in both animal models and patients. We also discuss recent studies associated with compromised mitochondrial function in various psychiatric disorders, such as schizophrenia (SCZ), major depressive disorder (MD), and bipolar disorders (BD). These studies employ various approaches including postmortem studies, imaging studies, genetic studies, and induced pluripotent stem cells (iPSCs) studies. We also summarize the evidence from animal models and clinical trials to support mitochondrial function as a potential therapeutic target to treat various psychiatric disorders. This review will contribute to furthering our understanding of the metabolic etiology of various psychiatric disorders, and help guide the development of optimal therapies.
Keyword:
Mitochondrial dysfunction
Psychiatric disorders
Schizophrenia (SCZ)
Bipolar disorder (BD)
Major depressive disorder (MD)
Induced pluripotent stem cell (iPSC)
期刊
IF:
3.5
论文数:
1.7W
被引数:
2.2W
机构
引用论文
iPSC-derived homogeneous populations of developing schizophrenia cortical interneurons have compromised mitochondrial function.png)
MOLECULAR PSYCHIATRY
OAAI
MOLECULAR PSYCHIATRYIF10.1
OAAI分享收藏
查看更多内容